CRISPR Gene Editing Had a Breakthrough Year--and It's Only Getting Started

CRISPR ended 2023 with a bang. In November, the gene editing tool scored its first clinical approval for treating sickle cell anemia and beta-thalassemia in the United Kingdom. These painful blood disorders are caused by a single genetic typo which distorts blood cells' shape and limits their ability to deliver oxygen. A few weeks later, […]